Digital Technology for Improved Access to Psychological Therapies (IAPT)
How can digital technologies assist in the assessment, diagnosis and treatment of psychological problems in primary care within Adult Improved Access to Psychological Therapy (IAPT) services?

Ideas (Psychological Therapies)

Innovation 'Elevator Pitch':
MyCognition improves: 
the effectiveness of psychological therapies services,
supports those waiting to access services,
supports long-term follow up,
& helps reduce relapse.
IAPT staff too benefit from improved mental resilience & better job performance.
Overview of Innovation:
MyCognitionPro is an innovative mobile app and reporting platform to monitor and build mental resilience, improve mental health and boost productivity. We focus on measuring the root cause of behaviours and the single biggest risk factor for mental health, 'cognition'. In the NHS we are deployed to identify long-term conditions patients and staff most at risk of developing severe mental illness or burnout with our personalised intervention providing treatment and continuous support. The platform is interoperable with other platforms and monitors and reports changes in cognition and mental resilience.
 
Our app has three programmes:
  1. MyCQ a clinically validated, 15 min assessment, that measures and tracks a person’s cognition across 5 key domains.
  2. AquaSnap a personalised algorithm cognitive training game to increase mental resilience and boost productivity.
  3. A Healthy Habits Builder to coach and sustain positive behaviour change.
In the IAPT setting MyCognition;
  • will improve the quality of referral pathways with a time and cost effective evaluation of patients most at risk,
  • support patients on waiting lists for IAPT services so their mental resilience is maintained,
  • improve cognitive states thus increasing the effectiveness of psychological therapies services,
  • and post treatment maintain good mental health and help reduce relapse.
Our solution is regulated by the MHRA and CE marked as a medical device; and approved by NHS Digital and ORCHA. It is evidenced from over 50 studies and feasibility pilots in depression, schizophrenia, OCD, PTSD, MCI, Parkinson’s, diabetes and breast cancer. It is currently deployed by GPs in long-term conditions and available for digital therapeutics referral through the EMIS App Library in London and is part of the NHS Good Thinking programme for the mental health of Londoners. It is promoted by the East Midlands AHSN's Digital Health Accelerator 2019-2020 Programme.
 
As well as patient healthcare, our app has supporting evidence for use by IAPT staff. Like patients, they too will benefit from building their mental resilience to deal with the pressures of their roles and simultaneously protecting  their mental health. Boosting their cognitive abilities will improve productivity and job performance. All of which is good if you are the employer concerned about employee job satisfaction and staff retention.

Click on our link: https://mycognition.com
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
MyCognitionPro is new digital solution that has the potential to be of considerable positive impact clinically and financially. It is considered to be not only an alternative  therapeutic intervention to address patient choice. But also, a means to improve the effectiveness of IAPT per say. With ‘effective referral and sustained recovery’ being the aim of the clinical pathway. MyCognitionPro improves equitable access to services, and ensures that patients most at risk of severe mental illness receive prompt support, by measuring and risk profiling their cognitive health state.
Those lower risk patients awaiting treatment can benefit from MyCognitionPro  preventing worsening of mental health condition. Whilst priming their cognitive abilities will mean that subsequent treatment or therapy is likely to be more effective and have a greater chance of success. Used in conjunction with therapy will deliver higher success rates and reduce relapse rates. Post therapy, MyCognition is an important solution to support patients’ recovery helping to reduce the potential for relapse. Monitoring data is useful to detect changes in mental resilience and determine if patients are experiencing early relapse. The efficiencies gained make for considerable savings and improvements in the cost effectiveness of therapies. Just as MyCognitionPro works for patients it also meets the needs of IAPT and NHS staff. With the added benefit of improving cognitive performance and productivity enabling them to perform better at work and stay in their role happily for longer. 
There is no limit on how often a user uses the applications functionality. However, we do expect minimum usage in order to demonstrate efficacy. Each patient/employee is registering for a year’s subscription to the application’s full functionality. Our low cost pricing is per user on a volume discount pricing model. We provide providers with either a charged model to administer the service or free self-administration access to the platform. Either require no additional overheads, treatment rooms, travel costs or other traditional overheads seen within the NHS. 
We are in a unique position of being able to measure, track and alert changes in cognitive state and mental resilience. Data and systems can be integrated into EHR systems providing powerful insight when combined with physical health data. Which in itself can be used in clinical research to develop improvements in mental health care.
GDPR compliant and ISO certed.
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
MyCognitionPro is scalable to benefit population in the East and West Midlands enabling them to access land utilise local IAPT services more effectively from ‘Referral to Recovery’ by
1. Improving patients’ access to the IAPT service, making sure patients most at risk of severe mental illness receive prompt support, by measuring their cognitive health state with MyCQ;
2. Preventing worsening of mental health conditions in patients on waiting list, by regularly monitoring their cognitive health with MyCQ and providing them access to our intervention AquaSnap, to improve their mental resilience;
3. Supporting patients over the entire therapeutic journey by strengthening cognitive functioning with AquaSnap, thus improving compliance and the effectiveness of response to psychological therapies services;
4. Supporting patients’ recovery and reducing the potential for relapse post therapy with access to the MyCognition app. Allowing them to monitor, strengthen and consolidate their mental resilience and prevent them to fall back in an illness state.
 
Just as MyCognition is suitable for referred or self-referral patients. It will also meet the needs of IAPT and other NHS staff struggling with the demands of their role and worried about their mental health and mental resilience. MyCognitionPro has the added benefit of being proven to improve productively and job performance. For employers this will help prevent staff ‘burnout’, improve productivity, job satisfaction and staff happiness and improved retention.
 
Results from clinical trials and real world studies report significant improvements, following AquaSnap training, in cognitive functioning, mental health, quality of life and psychosocial functioning, including ability to work and academic achievement, household, social activities, private activities and relationships. 
 
MyCognitionPro has the potential to make a positive change to the current patient mental health services for East and West Midlands population, as well as providing support for staff mental health and well-being.
 
You can view the MyCognition explainer video here:
https://www.youtube.com/watch?v=u1QqifDOdZ4

As well as a video by Professor John Harrison who explains in more detail why your cognition is important to your mental health here:
https://www.youtube.com/watch?v=W_RImzcfdEw

We have attached an overview of how we currently support the NHS.
 
Current and planned activity: 
The MyCognition App was launched in 2018 and now that it is approved and regulated, as a medical device, is on the NHS suppliers list and G-Cloud 11, is AHSN supported and is becoming established in the NHS commercially we are focusing on its use in IAPT care.
We are actively engaging with several NHS mental health commissioners of IAPT care across England to introduce it into their IAPT service provision. With particular focus on the east midlands region since we are a digital health partner in the East Midlands Digital Health Accelerator 2019-2020 Programme and will be working with them to commercialise MyCognitionPro in IAPT services in their region.
We want to work with commissioners and third party IAPT providers like Ieso, to enhance and improve the effectiveness of existing and new contracted patient psychological therapies services across the region and nationally. And develop services for IAPT and NHS staff who are struggling with their mental health and mental resilience. 
 
What is the intellectual property status of your innovation?:
Our IP sits over our software code, our methodology of assessment and training, our algorithms and personalised treatment and lastly the coaching aspects of our application. Powered by 20,000 data points.
MyCognition has patents pending in Europe and Canada.
 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Co-Authors:
Read more
Hide details
Martina Ratto 10/10/2019 - 13:48 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Big White Wall provides accessible, evidence based online therapy via a secure platform. Sessions are available 7 days a week between 7am and 11pm, providing enhanced accessibility. KPI's are fully reportable and the service is CQC regulated. 
Overview of Innovation:
Big White Wall (BWW) is a digital mental health support service which has been operating since 2007 and has supported 150,000 members in distress.

BWW provides Live Therapy, which is face to face therapy via the secure platform. Our clients, can complete sessions via video, audio only or text only. We provide NICE guided, evidence based interventions for common mental health disorders, such as OCD, Social Phobias, PTSD, Panic, Depression, GAD, Health Anxiety and Specific Phobias.

Many of our existing commissioners are IAPT services and we are fully IAPT compliant in our delivery including the sessional collection and reporting of the minimum dataset (MDS). Performance data can be submitted by the referrer themselves, either by collecting and inputting data from our platform or through the IAPTus PRISM integration, which feeds session data (clinical notes, attendance data and MDS) directly into the referring IAPT service's own IAPTus system. Or BWW can also submit data through the BWW IAPTus system which allows us to report data directly via an N3 connection, into NHS Digital under the appropriate service code.

We provide both NICE guided evidence based CBT and Counselling interventions and all of our Counsellors are additionally trained in Counselling for Depression. We also have a team of Long Term Conditions specialists (IAPT LTC Top Up trained) who can provide specialised interventions for those experiencing physical health issues. All of our therapists are professionally accredited and are experienced with at least 2 years post-accreditation.

We are CQC registered for our Live Therapy provision and remain the only digital service to have received this registered status. Our governance systems are therefore acknowledged to be safe and robust. We are included in the NHS Apps Library, requiring stringent assurance that we meet national standards, regulations and industry best practice.
 
Live Therapy at BWW is available between the hours of 7am and 11pm, seven days a week. We are able to meet an accessibility standard that many IAPT services are unable to achieve.

We are able to scale up or scale down provision according to demand and our waiting times to assessment / first therapy session are often measured in days rather than weeks or months. We are able to implement new contracts at pace. 

We also provide clinically moderated peer support on the platform 24/7, which can augment patient self-management and provide intersession and pre . post treatment support.

 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
The benefits to the NHS of using BWW to deliver services include;

a) Eliminating unwarranted variations in health indicators and the outcomes of care - through the utilisation of national standardised measures and KPIs.

b) Improving and increasing equitable access as outlined in the Five Year Forward View for Mental Health, by providing digital interventions, not reliant on geographical location, not limited by affordability or complexity of transport. Available nationally online to all, removing socio economic barriers, with hours of service availability outside the scope of normal IAPT service provision. Clients can access high quality support from the comfort and safety of their homes.  

c) Giving the best possible experience for patients and carers by providing a high level of customer support and service satisfaction. Measured by standardised Patient Experience Questionnaires (PEQs) and survey data.  

d) More cost-effectively integrating care and resources around the needs of patients and populations though specialist LTC interventions.

e) Reducing healthcare utilisation costs (survey data reveals usage of BWW (peer support network) reduces GP / acute service usage across populations).

f) Reducing social isolation, stigma and associated costs in decreased in wellbeing, and increases in physical health decline and frailty

g) Population based access to BWW, provides early and easy access to mental health support, which aids the prevention and early identification of MH issues.

h) Use of BWW to provide services improves patient choice. Members can choose to remain within the sphere of clinically moderated peer support and self-manage using resources and self-directed courses or can engage with Live Therapy and can select a modality and mode of treatment.


i) Provides an embedded, scalable, evidence based solution which is cost effective, high quality and safe.

 
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
Benefits to the WM population as outlined for the NHS
Current and planned activity: 
BWW provides services for several CCG's, Local Authorities and NHS Trusts, augmenting IAPT service provision. BWW has recntly completed a successful single point of access pilot for a London CCG, which allowed for population based self-referral into BWW Live Therapy. BWW submitted monthly data to NHS Digital and reported monthly recovery rates as high as 68% against a nationally set target of 50%. 

BWW is contracted by the MOD and the Home Office to provide Support Network peer support services and is currently commissioned by over 70 UK Universities. BWW is also comissioned by governement in Canada (Ontario Telemedicine Network) and New Zealand to provide Support Network access. OTN video linked here; https://youtu.be/OLG_OMHU4-s

BWW continues to grow and use technology for good and is currently undergoing a refresh of the platform - which  will enable an enhanced user expereince as well as improve the capability to innovate, scale and incorporate new technologies which augment care. 
 
What is the intellectual property status of your innovation?:
Intellectual Property is owned by BWW.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Heledd Davies 09/10/2019 - 15:43 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Florence is a sophisticated digital platform used to deliver personalised, targeted behavioural psychology-based messaging, interacting with patients as the friendly non-judgemental  persona, “Florence” through familiar and accessible SMS texts. 
 
Overview of Innovation:
The NHS owned “Simple Telehealth” methodology on which Florence is based, has challenged clinical thinking about the role and effectiveness of messaging in healthcare, delivering better & faster clinical outcomes by improving patients’ motivation, engagement & adherence to their best practice healthcare regime.

100,000+ patients on from inception, Florence continues to stand out by consistently producing independently evaluated positive results across wide-ranging clinical applications irrespective of patients’ age, ethnicity, socio-economic background or clinical setting.

With an active not-for-profit Community of Practice & extensive independent evidence base including multi-region economic evaluation, Florence has already been applied within mental health cohorts targeting local needs & priorities, some examples here http://www.simple.uk.net/system/app/pages/search?scope=search-site&q=mental+health

The integration of Florence into a psycologyical therapies pathway at King's Mill Hospital, Nottingham has been shortlisted for 2019 HSJ "Innovation in Mental Health" award "Enhancing psychological therapy for cancer and palliative care patients and relapse prevention: a digital health intervention" I am happy to introduce you to the Clinical Psychology Lead, Dr Sam Malins for an independent discussion.

The Simple Telehealth methodology is based on simple, interactive, practical & academic behaviour change principles designed to deliver a low cost approach for the NHS.  It is the intelligent mixture of the almost invisible technical platform, subtle methods and psychology that invoke responses from patients akin to engagement with their own clinician that results in such high satisfaction and efficacy.  The methodology balances the needs of the clinical community with the everyday needs of patients & their aspiration to carry on life as normally as possible despite having a condition that needs regular and consistent management. 

Florence allows clinicians to design specific protocols for large cohorts or an individual patient, where a patient’s health will benefit with improved health literacy or improved adherence to a shared clinical management plan.  Once enrolled, interactions can be personalised to suit the complex needs of an individual patient or left to follow templated best practice guidance, such as for diagnosis of hypertension. 

Florence creates a genuine partnership between professionals and patients, moving towards shared responsibility for health
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Advanced diagnostics, genomics and precision medicine / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Patients increase their motivation and engagement in the shared management of their mental health and consequently improve their clincial outcomes, faster. Whether this be in becoming more compliant with medication, putting into practice new techniques learned through face to face contact or many other applications, by following clinical guidance more thoroughly and developing what become sustained behaviour changes, both the patient and NHS benefit. As an example NHS Highland report that they improved the CBT Beating the Blues programme completion rate by 30% with Flo wrapped around.
  • Reduction in the likelihood of crisis episodes as a result of non compliance
  • Reinforcement of management strategies which help patients cope with symptoms
  • Can provide clinicians with additional insight into patients’ subjective measurement of their mental health condition to inform clinical sessions
  • Improved risk reduction for modifiable risk factors
  • Reduction in costs to the NHS associated with additional clinical sessions required as a result of a prolonged treatment pathway due to previous non compliance
  • Reduction in DNA rate where poor engagement increases likelihood of non attendance
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Florence provides a low cost and scalable opportunity for population health coverage targetted at solving local challenges where improved engagament and adherence would impact on both the patient and service. Flo requires the patient to have only a basic mobile phone so is accessible and familiar and has high levels of patient and clinician acceptance. Flo is free for patients to use in the UK.
Mental health cohorts where supported by Flo feedback signifcant quality of life improvements as a result not only of becoming more compliant with treatment regimes but also of not feeling alone, feeling supported and connected to their clinician when the go about their day to day lives.
Improved mental health has significant, known benefits to other social ascpects of both personal lives and contribution to society. 
Current and planned activity: 
Flo is currently commissioned by NHS organisations to support their patients and services according to local challenges. Once commissioned, support is included to develop pathways integrating Flo targetted at local priorities or to access the learning from existing applications withi the Simple Telehealth Community of Practice. Critically, being part of the Community of Practice means uses need to be evidence based so the design of uses, evidence and sharing studies and evaluation is key to the whole community.  The culture is that it is as important to share what doesn't work as what does work and how that has been achieved. Our primary objective is to invest in organisations for the long term to continually increase their capabilities to ensure patients and the organisation benefit from evidence based implementations for the lowest possible cost.  Our commitment to do the right thing for the right reasons for the benefit of patients.
What is the intellectual property status of your innovation?:
The NHS Stoke-on-Trent owned Simple Telehealth methodology including patent GB2483829, encompasses the design and methods to implement and exploit a sophisticated digital platform to deliver personalised, targeted behavioural psychology-based messaging, interacting with patients as a friendly, non-judgemental  persona
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
4
Read more
Hide details
Lisa Taylor 08/10/2019 - 16:47 Publish Login or Register to post comments
6
1
Votes
-99999
Innovation 'Elevator Pitch':
SAPIO aims to digitally transform the referral to treatment pathway in IAPT services, from an initial standardised digital assessment through to machine learning based insights using the historic IAPT dataset around treatment options and engagement.
Overview of Innovation:
SAPIO aims to provide a series of software modules, or features, within IAPT electronic patient record systems that will:
  • Streamline and digitise each stage of the patient journey from the point of referral, through assessment and appointment booking, to the start of treatment. 
  • Leverage historical IAPT patient data at key decision points in the pathway for insights about how individual patients could respond to treatment. This could support therapists by signposting treatment options that have been effective for similar patients in the past.
  • Establish patterns of patient engagement through the use of predictive modelling, so that therapists might preempt patients at risk of dropping out and take action.
  • Use greater standardisation through the assessment stage, along with IAPT’s excellent data collection around diagnosis, treatment and outcomes, to improve the opportunity for even more reliable treatment insights into the future. 
Modules within SAPIO include:
  • Standardised and digitised assessment that can be completed remotely by the patient as a first step.
  • Digitsed triage based on assessment.
  • Direct appointment booking by the patients.
  • Treatment insights.
  • Engagement insights.
  • Patient and clinician behavioural preference profiling and matching.
SAPIO is a research project conducted by Mayden, the creators of the iaptus patient management system used by most IAPT services in the NHS in England. It is funded by the Small Business Research Initiative (SBRI). Phase 1, also funded by SBRI, tested feasibility and initial results suggest a clinical demand for a standardised and digitised assessment, as well as interest in treatment and engagement insights based on analysis of the historic IAPT dataset. The algorithm was able to predict whether or not a patient will recover from a given treatment type with precision greater than 90% and accuracy of 68.90% (+/- 0.83%). This has the potential to increase recovery rates by 12.5% (from 50% to 62.5%), and, for patients who did recover, to improve outcomes by a further 5%. 

A prototype standard digital assessment was used by more than 800 patients a month in one IAPT service during Phase 1, and is already being adopted by other services. 
Stage of Development:
Evaluation stage - Representative model or prototype system developed and can be effectively evaluated
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
SAPIO's modules aim to:
  • Speed up access to assessment and treatment; shorter waits between referral and subsequent stages in the assessment and treatment pathway
  • Reduce administration
  • Save clinic time by standardising and digitising assessment
  • Give patients wider choice of access and treatment; patients given the ability to book their own appointments, tailored appropriately
  • Patients not appropriate for IAPT screened-out sooner and signposted to alternative support
  • Avoid drop outs and wasted appointments by improving engagement and retention of patients suitable for treatment
  • Improve outcomes
  • Ciinician decision support through targeted treatment insights
  • Streamlined workflow
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
As for the wider NHS above.
Current and planned activity: 
Phase 2 is currently underway and due to complete Summer 2020. Some modules will become available earlier. Services interested in co-creating or testing any modules can get involved now here: https://sites.google.com/mayden.co.uk/sapio/sapio?authuser=0 
What is the intellectual property status of your innovation?:
Mayden owns all relevant IP.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Alison Sturgess-Durden 04/10/2019 - 15:24 Publish 1 comment
0
0
Votes
-99999
Innovation 'Elevator Pitch':
The groundbreaking, secure hub that allows therapists to seamlessly and securely refer patients for online psychological treatment, and receive progress notes and outcomes data directly back into their NHS electronic patient record.
Overview of Innovation:
The Prism referral hub connects psychological therapy services with a variety of online digital therapies. Prism enables services to seamlessly and securely refer patients to a chosen online therapy and receive progress notes and outcome measures back, all from within their NHS electronic patient record. 

The Five Year Forward view for mental health and NHS Long Term Plan set ambitious targets to widen access to Improve Access to Psychological Therapies (IAPT) services across the country. This can only be achieved with greater uptake of online therapy options alongside growth in face to face and group therapy.

Prism was designed to make it easy for IAPT services to make use of online therapies. When a referral is received into the iaptus patient management system used by the majority of IAPT services, that patient can be referred straight through to a chosen online therapy partner from within the patient's electronic health record in iaptus so they can start virtual treatement without delay. The online provider can then securely send progress notes and outcome measures straight back into their health record. Previously, referring to an online therapy provider required, at best, laborious copying and pasting, or, at worst, a serious data quality challenge often with significant administrative support. The Prism hub has overcome all of this. Services gain efficiencies, patients have an improved experience, therapists can focus on the patient rather than admin, and outcomes are maintained – or even improved.

Since launching in 2014 Prism has been used by more than 60 IAPT services and currently handles 3000 referrals to online therapies each month. Prism is already  connected to Big White Wall, Compass, Dr Julian, ICS Digital Therapies, Living Life to The Full, Minddistrict, Silvercloud, Wellmind Media and OxCADAT SAIT with new online therapy partners being added all the time.

Prism was developed and is managed by Mayden. We have worked with IAPT services since 2008 to provide iaptus, the leading patient management software for psychological therapies. During this time, we have seen first-hand the limited resources and growing demand for IAPT services and recognise a need to provide innovative solutions that increase capacity.

Prism was developed with support from the NHS SBRI Healthcare initiative. We continue to work closely with IAPT and with a variety of online therapy providers to offer a breadth of choice for patients and services.
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Services gain efficiencies by making use of online therapies for appropriate patients which can be cheaper and more cost effective than face to face treatments. Patients have an improved experience with immediate access to treatment, and virtual treatment being more convenient or preferred to face to face therapy. Therapists can focus on the patient, rather than administration of referrals and can maintain an overview of the patient using digital treatments. They may also blend digital with face to face where clinically appropriate. Outcomes are maintained – or even improved - through online therapies.
Initial Review Rating
4.60 (1 ratings)
Benefit to WM population:
As for the NHS as a whole.
Current and planned activity: 
Prism is connected to ten digital providers. It handles around 3000 referrals a month now, and is used by 60+ IAPT services across England. We continue to add new online digital partners to the Prism platform.
What is the intellectual property status of your innovation?:
Mayden holds the IP for Prism.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Alison Sturgess-Durden 02/10/2019 - 11:30 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
Ieso Digital Health delivers NICE recommended cognitive behavioural therapy (CBT) one-to-one between patients and IAPT trained therapists via online (live) typed conversation. Appointments are available when suit patients on any web enabled device.
Overview of Innovation:
Ieso Digital Health (“Ieso”) provides NICE recommended cognitive behavioural therapy (CBT) through our proprietary 'ThinkWell' web-based platform. Both Step 2 and Step 3 therapy is delivered one-to-one between a patient and an IAPT-trained PWP or a BABCP-accredited high intensity therapist online through typed conversation, supported by offline messaging in-between sessions; treating all IAPT-applicable conditions:
  • depression
  • generalised anxiety disorder
  • social anxiety disorder
  • panic disorder
  • agoraphobia obsessive-compulsive disorder (OCD)
  • specific phobias (such as heights or small animals)
  • PTSD
  • health anxiety (hypochondriasis)
  • body dysmorphic disorder
Ieso’s fully-managed service has been developed in association with, and operating within, the NHS IAPT services since 2011. We have steadily built up our customer base and are now commissioned in over 65 CCG areas across England, either working directly with the CCGs or as sub-contractors to NHS Trusts and independent healthcare providers. To date Ieso have treated in excess of 43,000 patients and conducted over 210,000 hours of therapy within the IAPT programme.

Ieso summary information sheet is attached for review.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Digital health / Innovation and adoption
Benefit to NHS:
With growing demand for psychological therapies, traditional services can struggle to maintain NHS service standards relating to access, waiting times and recovery. As a result, services from around the NHS need to consider how to extend their care to patients without increasing their costs; including delivering digital interventions for appropriate cohort of patients. Although our service utilises the same human resources for the therapy itself, we have no additional overheads with regards to room hire, travel costs or other traditional overheads seen within the NHS.

Ieso's financial model is focused around patient treatment with no limit on session numbers. Pricing is based upon per episode of care, meaning a certain number of patients will be treated as part of allocated budget rather than assumed therapist capacity. 
 
Analysis of that data (Jan-Dec 2017) shows that Ieso delivers:
  • 22% better outcomes than the national average
  • 48% more patients’ complete treatment than the national average
  • 96.5% accessing treatment within 6 weeks, compared to 93.7% nationally, but with no waits for subsequent appointments.
In addition, Ieso’s “patient experience questionnaire” data shows that 82% of patients rate Ieso as good or excellent, and 66% of patients’ treatment is conducted outside of normal office hours.
 
The benefits of our innovation are not limited to quick and flexible access to treatment and better outcomes for patients. Our unique position of having access to extensive patient data can be used in clinical research to develop improvements in mental health care:
• Catarino, A. et al. (2018) Demographic and clinical predictors of response to internet-enabled cognitive–behavioural therapy for depression and anxiety. BJPsych Open (attached.
• Ewbank, M. et al (2019) Quantifying the Association Between Psychotherapy Content and Clinical Outcomes Using Deep Learning (attached)
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Patients are able to access clinically validated, NICE-approved, one-to-one typed CBT with an IAPT-trained PWP or BABCP-accredited high intensity therapist from the comfort of their own home using nothing more than their smartphone, tablet or computer to access our ThinkWell platform via a reliable internet connection.

With appointments available 24/7, traditional CBT can be conducted at a time and place that suits the patient. This means that those who are time poor, struggle to access traditional services due to geography, physical difficulties or personal boundaties are able to access the treatment that's right for them.

Approximately 66% of Ieso’s therapy sessions happen outside the traditional Monday-Friday 9-5 window,
with the majority taking place on week day evenings; in addition, Ieso’s “patient experience questionnaire” data shows that 82% of patients rate Ieso as 'good' or 'excellent'.

You can view an Ieso explainer video here:
https://www.youtube.com/watch?v=H5cID-JGSXU

As well as a 'people' video showing some of the people behind Ieso Digital Health here:
https://www.youtube.com/watch?v=ryIFZNBVkhk

We have also attached a patient case study.
Current and planned activity: 
Ieso manages IAPT contracts with large footprints, such as in Surrey, where we treat approximately 20% of the total number of patients accessing IAPT across the five CCGs within the AQP contract. In addition to Surrey, Ieso holds 26 IAPT contracts delivering a Primary Care Psychological Therapies Services. These contract areas are listed below;
•        Bolton
•        Bromley
•        Camden
•        Cambridgeshire and Peterborough
•        Derbyshire
•        Devon
•        Dorset
•        Dudley
•        East Riding of Yorkshire
•        Gloucestershire
•        Buckinghamshire
•        Herefordshire
•        Islington
•        Lancashire
•        Leeds
•        Medway
•        Merton
•        Norfolk
•        Nottinghamshire
•        Salford
•        Southampton
•        Southwark
•        Suffolk
•        Sussex
•        Wandsworth
•        West Kent

We continue to expand enabling more and more people to access clinically-validated CBT at a time and place that suits them.
What is the intellectual property status of your innovation?:
All IP is owned by Ieso Digital Health.

Ieso is ISO9001 and ISO27001 compliant and our IG Toolkit for 2017-18 (v14.1) had an overall score of
95%.

Ieso is fully operable with all major patient management systems (IAPTus, PCMIS).
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Read more
Hide details
n.wallace-davies@iesohealth.com 23/09/2019 - 17:28 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
CheckWare for digital clinical assessment & remote patient monitoring in Mental Health, Physical Health and Long-Term conditions. Automates the delivery, scoring, comparison and reporting of over 1,200 authorised assessments (all IAPT)
Overview of Innovation:
CheckWare – a brief summary
 
  • CheckWare is for Healthcare organisations that want to offer secure, digital clinical assessment and remote patient monitoring in Mental Health, Physical Health and Long-Term conditions
 
  • CheckWare delivers secure eHealth solutions that automate the delivery, scoring, comparison and reporting of over 1,200 authorised clinical assessments and tests. (including all IAPT assessments)
 
  • CheckWare makes it possible for patients to participate digitally in their own treatment through self-reporting.
 
  • By replacing paper-based procedures, CheckWare securely increases treatment efficiency and proves clinical outcomes
 
  • CheckWare is the only solution for the digital automation of clinical assessment and PROM and to have the digital rights to over a thousand clinical assessment tests and outcome measures.
 
  • CheckWare digital assessment tests and questionnaires are already used within a clinical environment, community or clinical research.
 
  • The data collected is automatically and immediately available for clinical, patient or research reporting and feedback and for proof of outcome measures.
 
  • CheckWare can, where appropriate, empower the patient (or parent) to “self-report” between clinical appointments – allowing clinicians to prioritise waiting lists or be automatically informed of any patient health changes or deteriorations.
 
  • CheckWare provides the ability to create assessment pathways to reflect working processes, and to assist in patient interaction.
 
  • Additionally, CheckWare can be used to automatically set goals, provide reminders, feedback and content (text, video, URL etc).
 
  • The CheckWare system has a secure open API (Application Program Interface) – and has been integrated into multiple different EPR and PAS systems
 
  • Aggregated data can be exported from the system for either reporting or research (SPSS format if required) – or could be viewed on the on-line clinical dashboards
 
  • The CheckWare system is secure - compliant with HL7 and with IG / NHS Toolkit standards and resides on the N3 NHS Network.
 
  • CheckWare has been licenced in multiple NHS organisations and in over 360 organisations throughout Europe.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
Prove outcome measures through aggregated data, reduce use of paper based assessment tests, automatically score and report at point of care, prioritise waiting lists, automatically alert and react to patient health changes. prevent unnecessary clinical appointments, automate any royaly payments due.
Initial Review Rating
4.40 (2 ratings)
Benefit to WM population:
Prove outcome measures through aggregated data, reduce use of paper based assessment tests, automatically score and report at point of care, prioritise waiting lists, automatically alert and react to patient health changes. prevent unnecessary clinical appointments, automate any royaly payments due.
Current and planned activity: 
Already engaged (in a small way) with the NHS - need assistance to broaden our engagement and customer base a
What is the intellectual property status of your innovation?:
IP is wholly owned by CheckWare
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Read more
Hide details
Anonymous 03/09/2019 - 14:27 Archived Login or Register to post comments
0
0
Votes

Innovation 'Elevator Pitch':
Dr Julian is an innovative mental healthcare platform that aims to increase accessibility of mental healthcare. We connect patients to mental healthcare professionals by secure video/audio/text using a calendar appointment booking system.
Overview of Innovation:
We empower patients allowing them to see who they want to see when they want to see them where they want to see them and how they want to see them, they can choose who they want to see from a list of available therapists and can filter via issue (depression/anxiety etc)/ language/ therapy type/ date/time, therefore finding the therapist that meets their needs. They then book with the therapist on the system and then have the appointment on the system. They therefore can have the appointment from wherever they want so long as they have Internet access. 

Notes are then stored securely on that patients profile on the system. 

Patients take assessments on the system in line with NHS data requirements, which are stored on the patient’s profile. 

Patients have access to their assessment results through their dashboard at any time and they can use the platform for taking and viewing assessments i.e. GAD7 and PHQ9 both during and post NHS treatment including the ability to book further appointments privately.

The platform can store any communication between the patient and therapist in regard to advice and suggestions that they may make in regard to treatment and which are available to the patient at all times.

We can create unique customised sub portal domains we call ‘tenancies’. This can be branded to the NHS trust and have a customised registration form and patient’s notes template. This allows customisation to help NHS staff. We are currently being used in IAPT services with an 80% recovery rate as compared to the NHS under 50%, we are also being used by a number of corporate organisations providing mental health for their employees and could be used by the NHS to help their staff.

We assign therapists to the individual tenancies so that only these show up. This way if an IAPT provider only wants CBT therapists currently working within IAPT they can have this. If they want a pain psychology service we only upload the pain psychology therapists to this tenancy. 

A trust could use its own therapists for this platform or could utilise our network providing out of hours and weekend appointments and at periods of high demand.

We can assign admin permissions to NHS staff to onboard patients to the system, see and download the patients notes/ registration/ assessments. When a patient is onboarded they can be assigned a set number of appointments, which is editable. 

We have integrated with the PRISM system to allow automatic upload of this data into NHS IAPT systems. 
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Education, training and future workforce / Wealth creation / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:

Workforce provision. NHS can struggle to recruit therapists. As the platform has no barriers of location of the therapist as they work from home it can utilise a workforce nationally and even internationally improving workforce provision and efficiency. It also brings those who may have taken a break from the NHS e.g. Maternity leave the ability to come back and work and provide for flexible working with the therapist putting up availability when it suits them to work.

Cost saving could save the NHS £29 million per annum if only 10% of current NHS face to face mental health appointments were undertaken using video technology. Our Cost for step three patient per appointment £60 NHS national average £100-160 (unit costs of social care).

Dr Julian reduces time taken off work by patients by allowing therapy appointments to be undertaken at the convenience of the patient around their life-style/work 24/7 therefore providing a benefit to the UK economy.

Dr Julian can assist with periods of high demand utilising our network of therapists nationwide and providing 7 day 24/7 help.


By utilising our platform we are able to create huge efficiency in the system and be 1/3 of the cost of traditional models of care. It enables us to utilise a national workforce  of therapists and enable patient choice of who they want to see and when. As therapists work from home it also provides out of hours appointments, is much better for them and allows them to work more efficiently via the platform. As assessments are undertaken on the platform that link with NHS systems it again makes the system more efficient as patients can undertake the assessment before the session maximising their therapy time with the need for minimal admin input as the system does most of the admin.

It also allows patients to see a leading expert in a particular area if they need potentially globally and allows them to be matched to the most appropriate therapist for them. We have already shown better clinical outcomes than standard practice with huge patient satisfaction.

It also helps those patients who may struggle to leave the house/ who are in remote areas and those that cant speak english as allows them to choose a therapist that can speak their language including sign language therefore helps ethnic and minority groups all they need is access to the internet which is ever improving.
 
Initial Review Rating
5.00 (2 ratings)
Benefit to WM population:
Dr Julian is currently being used in Thurrock, Lancashire on an going commercial contract and in Pilot with Oxleas, Milton Keynes and North London. It is gaining momentum with other IAPT services.

In a recent review of outcomes of our longest standing contract in Thurrock IAPT service we have delivered:

Improved recovery rates our recovery rate is 70%. The NHS average is 50%. Patient gets choice of therapist and therefore finds the right therapist for them, fast access to therapy at a time that suits them and from home.

Reduced DNA (did not attend) rates as the platform is built around patient choice. Our DNA rate is 5% as compared to the previous and NHS average over 20%.

Fast access to therapy reducing distress, symptomatology and negative thoughts/thoughts of self-harm. We have appointments available on the same day and all patients are able to book at a time of their choice within 2 weeks of receiving referral.

Dr Julian helps those house-bound and those who find it difficult to travel to appointments by allowing therapy appointments from wherever the patient finds them convenient such as their own home.

Dr Julian improves patient satisfaction as patients feel more comfortable accessing therapy from an environment they are more comfortable in with near 100% user satisfaction rating.

 
Current and planned activity: 
We are currently contracted with Thurrock Inclusion IAPT service, Lancashire Minds Matter with regular patients referred to us per month between 10-20 and increasing. This was post successful pilots with these two trusts. We are in pilot with Milton Keynes and Oxleas IAPT services with plans for longer term provision with them. We are in coversations with multiple other trusts who would also like to use our services due to the very positive word of mouth feedback from the other trusts. 
What is the intellectual property status of your innovation?:
We own all our IP 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Read more
Hide details
Dr Julian Nesbitt 23/08/2019 - 10:46 Publish Login or Register to post comments
0
0
Votes
-99999

Recent Activities

SAPIO Streamline Assessment Pathways Improve Outcomes has been moved from Initial Submission to Publish 2 months 2 weeks ago
Carl Plant voted on Florence: Simple Messaging Activating Patients to Deliver Better and Faster Outcomes 3 months 2 weeks ago
CheckWare - Digital Technology for Improved Access to Psychological Therapies has been moved from Initial Submission to Publish 4 months 1 week ago
MyCognitionPro to assess, monitor and improve the mental resilience of patients and staff; & improve IAPT services effectiveness has been moved from Initial Submission to Publish 4 months 2 weeks ago
BrowseAloud has been moved from Initial Submission to Publish 4 months 2 weeks ago

Active Campaigns